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Background: Lymphatic filariasis (LF) due to Wuchereria bancrofti is being eliminated from Oceania under the
Pacific Elimination of Lymphatic Filariasis Programme. LF was endemic in Solomon Islands but in the 2010-2020
Strategic Plan of the Global Programme to Eliminate LF, Solomon Islands was listed as non-endemic for LF. In
countries now declared free of LF an important question is what monitoring strategy should be used to detect any
residual foci of LF?
This paper describes how a new case of elephantiasis in a post-elimination setting may be used as a trigger to
initiate a local survey for LF.
Methods: The index case, a 44 year old male, presented to Atoifi Adventist Hospital, Malaita, Solomon Islands in
April 2011 with elephantiasis of the lower leg. Persistent swelling had commenced 16 months previously. He was
negative for antigen by TropBio Og4C3 ELISA and for microfilaria. A week later a survey of 197 people aged from
1 year to 68 years was conducted at Alasi, the index case’s village, by a research team from Atoifi Adventist Hospital
and Atoifi College of Nursing. This represented 66.3% of the village population. Blood was collected between
22:00 and 03:00 by finger-prick and made into thick smears to detect microfilaria and collected onto filter paper
for W. bancrofti antigen tests. A second group of 110 specimens was similarly collected from residents of the
Hospital campus and inpatients. W. bancrofti antigen was tested for using the Trop-Bio Og4C3 test.
Results: One sample (1/307) from an 18 year old male from Alsai was positive for W. bancrofti antigen. No
samples were positive for microfilaria. Although antigen-positivity indicated a live worm, the case was regarded
as having been acquired some years previously.
Conclusions: We propose that when LF has been eliminated from a country, a case of elephantiasis should be a
trigger to conduct a survey of the case’s community using a decision pathway. W. bancrofti antigen should be
tested for with screening for microfilariae in antigen positive cases. The field survey was designed and
conducted by local researchers, highlighting the value of local research capacity in remote areas.
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Lymphatic filariasis (LF) is of global concern as a major
cause of morbidity in many tropical countries. Following
the success of eliminating the parasite from industrial-
ized countries in its former range, the World Health
Assembly approved a global elimination programme [1].
The Pacific Programme for the Elimination of Lymphatic
Filariasis (PacELF) was formed in 1999 to coordinate the
control efforts in Pacific Island Countries and Territories
(PICTs) within the framework of the Global Programme
to Eliminate Lymphatic Filariasis [2]. The WHO target is
to eliminate LF as a public health problem, meaning that
the parasite may continue to circulate at a very low level
but new cases of clinical disease are unlikely to arise. The
elimination target is less than 1/10,000 cases in the popu-
lation [3].
PacELF and the PICTs are advised and assisted tech-
nically in the elimination programme by the WHO
Collaborative Centre for Control of Lymphatic Filariasis
and Soil Transmitted Helminths based at James Cook
University, Townsville. The main mechanism used by the
elimination programme to stop transmission of LF is com-
munity wide administration of oral albendazole and dieth-
ylcarbamazine every 12 months [4]. Of the 22 countries
within the PICTs LF was classed as wholly or partly en-
demic in 17. Fourteen of the endemic countries have
implemented Mass Drug Administration programmes [5].
When LF is close to elimination, it appears to persist in
countries as small geographic foci centred around indi-
vidual(s) with microfilaremia [6,7]. The surveillance
strategy proposed for the Pacific in the final stage of the
LF elimination programme is based on using children as
sentinels for ongoing transmission by detection of anti-
gen of W. bancrofti in the blood. Finding a positive child
will then initiate “close contact testing” in which sur-
rounding households are tested [8]. This strategy relies
on ongoing surveys of children for antigen. It is feasible
that LF could persist in remote locations too logistically
demanding to survey by researchers from national
programmes based in capital cities.
Solomon Islands, a PICT with a population of 525,000,
distributed over 8 provinces, has eliminated LF, possibly as
a spin-off of a very active malaria eradication programme
pre-1985 [9,10]. In a survey conducted using thick blood
films to detect microfilaria in the early 1940s the prevalence
of LF in the Solomon Islands was 19.6%, with the preva-
lence in Malaita (the province dealt with in this paper) be-
ing 10.2% [11]. By 1976 prevalence in Choiseul province
had declined to 5.5% [11] and to 2% in Guadacanal prov-
ince [9]. In Choiseul province the prevalence of mf positiv-
ity had fallen to zero by 1978 associated with spraying
for malaria control [10]. Microfilaremia was still present
in other provinces [10]. In 2002 a survey of primary
school children for antigen detected by ICT cards foundno positive cases [12]. In the 2010-2020 strategic plan of
the Global Programme to Eliminate Lymphatic Filariasis,
Solomon Islands was considered non-endemic for LF [5].
This conclusion was based on the opinions of a global
working group of experts, who reviewed all available evi-
dence [13] although no data on prevalence appears to
have been published for 30 years.
In a country that has reached the verification stage of
LF elimination expected surveillance activities include
(among other strategies) a review of filariasis case reports
through routine disease surveillance or other systems for
case detection plus a description of case follow-up activ-
ities for each positive case detected [14]. No criteria have
been proposed for countries that had LF in the past, did
not participate in the recent elimination programme, but
are now regarded as non-endemic for LF. Solomon Islands
is such a country.
Here we describe an instance in the Solomon Islands
where a new case of elephantiasis in East Kwaio, a remote
location on the east coast of the island of Malaita, was
used as a trigger to conduct a village based survey for LF.
The rapid response was conducted by a local team of re-
searchers based in this remote area and trained in oper-
ational research techniques.
Methods
Location: Malaita is a predominantly rural island to the
North East of Honiara, the capital of Solomon Islands,
with a population of 137,600. East Kwaio is on the re-
mote east coast of Malaita. Atoifi Adventist Hospital was
established in 1966 in East Kwaio and provides health
care, including surgery, in-patient and out-patient services
to the surrounding villages (8°52’11”S 151°00’14”E)
(Figure 1). Access to Atoifi is via small plane (twice weekly)
or boat. The village of Alasi, the location of the index case,
is a small isolated village (8°51’58”S, 160°59’41”E), approxi-
mately 6 km north of Atoifi, accessible by canoe across
Uru Harbour (Figure 1).
Clinical case of elephantiasis
On 11 April 2011 a 44 year old male presented at Atoifi
Adventist Hospital with a 16 month history of swelling
of his right lower leg, involving the foot, ankle and the
distal two-thirds of the tibia (Figures 2 and 3). The swell-
ing was painless, but the patient complained of heaviness
of the limb. Subcutaneous edema was demonstrated in all
areas by pitting on digital pressure for 15 seconds. On the
foot and ankle subcutaneous tissue was increased mark-
edly and felt dense to palpation, indicating fibrosis. The
overlying skin was thickened and covered with low, dome
shaped, smooth nodular lesions up to 5 mm in diameter.
On the foot these became almost confluent (Figure 4).
The foot was warm to touch. An irregular area of vitiligo
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Figure 1 Map. Map of Solomon Islands showing location of area of interest with a larger map of Uru Harbour showing Atoifi and Alasi.
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left ankle which was unaffected by swelling (Figure 2).
Inguinal lymph nodes on the right were enlarged, but
not tender. The patient was afebrile with normal cardiac
and respiratory rates. The clinical diagnosis was elephant-
iasis Grade IV, the grading being based on persistent,Figure 2 Both legs (anterior). Male 44 years from Alasi, Malaita,
Solomon Islands with swelling of right lower leg of 16 months
duration. Vitiligo is present on flexor aspects of both ankles and had
appeared before the limb swelling.irreversible swelling due to increased subcutaneous tissue
with knobs and lumps forming on the skin [15].
Medical records showed that the limb was normal in
April 2009 and that the patient had first presented with
swelling of the right foot on 15 February 2010. The pa-
tient was seen again on 24 Feb 2010 and 14 Feb 2011
with acute episodes of tenderness and swelling. At these
presentations the focus was on the clinical management
of the case.
Public health implications
Although Solomon Islands had been an LF endemic
country in the past, in 2011 it was considered to be free
of lymphatic filariasis. The case of recent elephantiasis
therefore raised the possibility that transmission of LFFigure 3 Right leg (lateral). Elephantiasis of right leg of 44 year
old male from Alasi, Malaita, Solomon Islands (lateral view).
Figure 4 Skin lesions foot. Nodular epidermal changes associated
with elephantiasis of right leg (medial view).
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2011 the patient had been seen purely as a clinical case
and the public health implications had been ignored.
However, once the local health professionals were made
aware of the programmatic significance of the case, they
were adamant that the index case’s community be inves-
tigated for active transmission of W. bancrofti.
Immediate response
Index case. The patient was given oral doxycycline, soap
to wash the limb and advice on care. The patient and his
wife were asked to attend the hospital at night to enable
a nocturnal blood collection for testing for microfilaria.
Blood was collected via venipuncture at 23:00 since in
the Solomon Islands W. bancrofti has nocturnal period-
icity [16]. Duplicate Knott’s concentration tests, examin-
ation of fresh unstained wet thick film (0.05 ml) and
Giemsa stained thick film for malaria (0.02 ml) was
performed on EDTA blood in the Atoifi Hospital Labora-
tory for both the patient and his wife. No microfilaria were
detected in either. Serum was subsequently transported to
Townsville, Australia and tested for W. bancrofti antigen
using the TropBio Og4C3 ELISA.
Community survey
The possibility of ongoing transmission of LF at Alasi
was presented in a formal lecture at Atoifi Hospital two
days later by author RS. The lecture was given during a
research symposium taking place at the hospital on 14
April 2011 to conclude a two week research capacity
building workshop [17]. The need to assess whether LF
transmission was current was then discussed with the
local research group at the Hospital. Owing to the nature
of the research training delivered, the research group
consisted of health professionals (nurses, doctor, and
pharmacist) and community leaders (village chiefs, pastors,teachers) all from East Kwaio [17,18]. No one in the group
was from Alasi, but several members had relatives who
lived in the village.
The group decided that the situation warranted a com-
munity survey to investigate the research hypothesis that
“Community members in Alasi village (particularly adults)
are infected with Wuchereria bencrofti and will have
microfilaremia”. From this point the field-based survey
was managed by the local group (all expatriats having
departed Atoifi).
Local research team representatives firstly set out to
talk to community people in Alasi village and to residents
of the Atoifi Hospital campus (most hospital employees
and their families reside on the hospital campus). The
Alasi community decided that the survey was valuable
and agreed to participate.
Blood was collected between 22:00 hours on 19 April
2011 to 03:00 on 20 April 2011 during a cross-sectional
survey of the residents of Alasi. At this stage travel histor-
ies were of no importance since the aim was to collect
specimens to enable LF to be ruled out. Residents from
houses surrounding the house of the index case were
given priority since the number of filter papers was lim-
ited. Finger prick was used and blood absorbed for each
person onto at least 3 filter paper ears, capable of holding
100 μl each. From each participant two thick smears were
made on glass microscope slides. Two techniques were
used to test for LF (see Laboratory Techniques).
As an additional group residents of the Atoifi Adventist
Hospital campus and some inpatients from surrounding
villages were also screened in a similar way between 22:00
on 20 April 2011 and 03:00 on 21 April 2011.Laboratory techniques
A two step screening process was used: firstly, serum
eluted from the filter paper ears was screened using the
TropBio Og4C3 ELISA to detect W. bancrofti antigen.
Secondly, any films of participants with positive or border-
line antigen results were examined. As a quality control
measure 10% of smears from antigen negative participants
were also examined.
The Og4C3 ELISA was performed as previously de-
scribed and as per manufacturer’s instructions [19]. All
thick smears were dried and stained unfixed with a stand-
ard Giemsa stain. Stained films were examined using a
compound light microscope and the ×40 objective.Ethics
Ethics approval was granted for the community survey by
the Atoifi Adventist Hospital Research Ethics Committee
(AAHREC4) and James Cook University Human Research
Ethics Committee (H4002).
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Written informed consent was obtained from the patient
for the publication of this report and any accompany-
ing images.
Capacity building component
The opportunity to conduct this survey came at the con-
clusion of a two week research capacity building workshop
held at Atoifi that had trained local health professionals
and community leaders in how to design and conduct
applied health research projects [17,18]. The survey was
designed as a collaborative process with the diverse re-
search group. Limited specific LF training was given,
including theory (the parasite and its life cycle, disease
manifestations, diagnosis, and significance of finding
elephantiasis in a LF-free region) and practical training
in collecting blood from finger prick onto filter paper.
The Solomon Island researchers conducted all commu-
nity consultations, led by HH and JA. The residents of
Alasi also agreed to walk for 20-30 minutes from their
village on the headland to the closest beach, where they
met the team from the Hospital who arrived by motorised
canoe. Participants were bled on the beach by torchlight.
Researchers from Atoifi Hospital and the College of
Nursing performed the survey and prepared filter paper
specimens and duplicate sets of blood smears: a setFigure 5 LF decision tree. Decision tree for initiation of a survey for LF
Wb = Wuchereria bancrofti.for Atoifi Hospital laboratory and a set for transport
to the WHO reference laboratory in Townsville. A team
from Atoifi Hospital, led by HH and JA, subsequently
informed residents of Alasi and Atoifi of the result of
the survey.
Results
A total of 307 samples were tested, 197 from Alasi and
110 from Atoifi. The samples collected at Atoifi were
from people resident on campus and (owing to participa-
tion by hospital inpatients) from 12 surrounding villages.
Samples were from: Atoifi (80), Gethsemane (1), Gwari (2),
Honoa (1), Ilanunu (4), Kwai (4), Kwalakwala (6), Loama
(1), Manano (2), Mamulele (1), Na’au (2), Namofaewa (2)
and Namolaelae (4). Since the total population of Alasi was
297 and of Atoifi campus 214, the number tested repre-
sented 66.3% and 37.4% of the Alasi and Atoifi popula-
tions respectively. The latter value included only residents
of the Atoifi campus as numerator and denominator, not
the hospital inpatients from elsewhere. Overall males
comprised 40.7% and adults 76.2%. The Alasi sample had
46.7% males, 68.0% adults and an average age of 25.6 years
while the other group had had 30% males, 90.9% adults
and an average age of 24.5 years.
One male from Alasi had a positive TropBio Og4C3
test (prevalence overall of 0.33% and for Alasi of 0.51%).in a PICT that is in the elimination phase or previously endemic.
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for most of his life and had no clinical evidence of LF.
The index case and his wife were seronegative. No
microfilaria were found in the blood film from the anti-
gen positive case or in films from 50 antigen negative
participants.
Discussion
The Og4C3 ELISA has a high specificity (95-100%) and
positive result indicates a live W. bancrofti is present; a
false positive is unlikely [20,21]. Although the antigen
positive case detected by this survey would have a live
worm, since he was microfilaria negative he had probably
been infected many years ago. By conducting a com-
prehensive survey to detect W. bancrofti antigen and
microfilaria in people living in the local environment of
the index case, any possible recent transmission can be
detected. In this case there was no evidence of trans-
mission in this area of East Kwaio. This result supports
the position that transmission of LF in Solomon Islands
has ceased and it is now non-endemic for LF. Such a
response to a suspected case of filariasis detected through
the primary care system could become a recommended
action under the verification process proposed by WHO
for countries post-elimination [14]. The decisions that
led us to investigate this case have been constructed
into a decision tree (Figure 5). This could form the basis
of similar investigations of elephantiasis or other mani-
festations of LF in the PICTs in the elimination phase.
The availability of a group of local health professionals
and village leaders trained in research theory and applied
research methods allowed the field aspects of the survey
to be conducted rapidly (within 1 week of presentation
of the index case) and at minimal cost. Specimens were
correctly processed and were sent immediately to the
international WHO LF reference laboratory in Australia
for more tests not available in Solomon Islands. The field
survey was funded from the Atoifi Hospital budget
and the laboratory costs in Australia from the WHO
Collaborating Centre budget. This highlights the import-
ance of sufficient ongoing funding to maintain such a
reference centre. Transport of specimens from Atoifi to
Townsville was at no cost by an Australian member
(DM) of the research workshop returning to Australia.
This rapid and very cost effective response highlights the
value of having remote health professionals trained in ap-
plied research [17]. In addition the local research team
felt immense satisfaction in being able to answer local
questions of potential national significance [17].
Conclusions
This model for responding to detection of a new case of
lymphoedema is simple and feasible. Field work can be
performed by local researchers with minimal resourcesand laboratory work by a laboratory specialized in LF
tests. In countries and regions where LF is eliminated,
detecting new cases of elephantiasis or acute lymphoedema
of appendages with no obvious alternative cause should
be the trigger for a local survey. To be able to do this
PICTs eliminating LF should maintain appropriate expert-
ise within their ministries of health / Neglected Tropical
Diseases Programme to keep up surveillance, follow up
suspected cases and carry out specific specialised tests
as required, including maintaining links with the JCU
WHO Collaborating Centre for the Control of LF and
STH for expert support. Funding to maintain such refer-
ence centres for LF control is essential. Finally, we rec-
ommend that such events should be recorded in a
national database which is then communicated to the
global LF programme.
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